Hay muchas formas de sumarte al #RetoMetástasis💪, la campaña del @IRBBarcelona para impulsar la investigación biomédica 👩🔬👨🔬 de esta enfermedad. ¿Ya conoces a nuestros colaboradores?👇
El Club Esportiu @elsibers organizó el 10 de marzo una carrera🏃♀️🏃♂️ solidaria a favor del #RetoMetástasis. Un gran plan, disfrutar del entorno del Parc de la Serralada Litoral y ayudar a la investigación de la #metástasis
¡Gracias a todos los participantes! retometastasis.com/p2p/809/wwwels…
Ester superó un cáncer de mama y desde entonces colabora con el #RetoMetástasis💪 a través de diversas campañas como la que lanzó con motivo de su cumpleaños o la venta de pulseras que hace ella misma. ¡Muchas gracias Ester! 😊 retometastasis.com/p2p/809/vidape…
En las catas 🍷 organizadas por @ViperVida todos los beneficios van destinados al #RetoMetástasis 💪. Hasta ahora han sido un éxito y ya estamos esperando ansiosos la siguiente. Muchas gracia a @xaviayala y todo el equipo 🙌🙌
Magdalena, una mallorquina paciente de cáncer, recorrió a pie 🚶♀️ La Sierra de Tramontana con el fin de visibilizar la lucha contra la #metástasis y a través de su campaña sigue colaborando con el #RetoMetástasis💪. ¡Muchas gracias campeona!👏 retometastasis.com/p2p/809/camita…
Más gente sigue sumándose al #RetoMetástasis💪. Como ellos, tu también puedes crear tu campaña. En el @IRBBarcelona estamos convencidos 😊 de que juntos conseguiremos la energía y la esperanza necesarias para ganarle la partida al cáncer.
Súmate!
➡️retometastasis.com
• • •
Missing some Tweet in this thread? You can try to
force a refresh
🔬An international consortium, led by #IRBBarcelona & the biotech company @MerusNV, reports the discovery of MCLA-158, the first clinical candidate screened in #organoids targeting 🎯 #cancer#stemcells of solid tumors.
Named Petosemtamab, the antibody MCLA-158 prevents the onset of #metastasis (that is, the spread of #cancer to other vital organs) and slows the growth of primary tumours in experimental models of cancer.
The study also lays the groundwork for the use of #organoids in the #DrugDiscovery process undertaken by pharmaceutical companies.
Organoids are patient-derived samples that can be grown in the laboratory, and they reproduce certain aspects of the tumour compartment.
#IRBScience: Published in @GenomeMedicine, the latest work from the SBNB lab points to the co-occurrence of #cancer driver genes as a key to precision medicine.
The system is called Targeted Cancer Therapy for You (TCT4U), and it's aimed at predicting tumour response to different treatments.💊
It has allowed the identification of a set of complex biomarkers🧬that have now been made available to the medical-scientific community.
(2/4)↘️
"The sum of two or more mutated #Cancer driver genes affects the tumour's response to treatments" says @ptck72, "through this work, we see that studying cancer driver genes as a whole can bring about a great advance towards precision medicine".
@Eduard_puig is one of the committed scientists who recently made an important contribution to the field.
(1/4)
In June, @Eduard_puig, @SoniaCiudad and Natalia Carulla, among others, revealed the specific ensembles of Aβ protein that have the capacity to disrupt the membrane of neurons, causing their death.
@IRBBarcelona coordinates the European Project Evomet to train 15 young scientists and future leaders in metastasis research with the aim to identify therapeutic solutions. The project has received €4 M and will last for four years.
Each of the institutions will host one of the selected young researchers and will train them until they complete their doctorate, except for @IRBBarcelona and @idibell_cat IDIBELL, which will host two predoctoral researchers each.
#IRBScience: The @bbglab publishes "A compendium of mutational cancer driver genes" in @NatureRevCancer, with mportant implications in clinical decision making.
📢568 genes identified with the potential to trigger #cancer!
The study stands on the analysis of the genomes of 28,000 tumours from 66 types of cancer and it's a major update of the #IntOGen platform (intogen.org), aimed at identifying mutational cancer driver genes.
(2/5)
“The compendium of driver genes provides cancer researchers, both in the clinical and basic research setting, with crucial knowledge and it has an important impact on clinical decision-making,” says @nlbigas, head of the @bbglab at @IRBBarcelona and @icreacommunity.